Clinical and morphological features of the wound healing process when managing simulated wounds with a sodium selenite and metronidazole-based medicinal product

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. Currently, one of the major problems in surgery is the treatment of wounds and trophic ulcers. The relevance of this problem results from the fact that the concept of the wound process and its mechanisms are constantly changing due to the development of surgery and related disciplines.

Aims. The aim of this experimental study was to compare the clinical and morphological features of the wound-healing potential of the developed medicinal product in managing the first (I) and second (II) phases of the wound process.

Material and methods. An experimental study involved 36 male Wistar rats. In the study, we evaluated the effectiveness of the developed medicinal composition on wound healing. After wound simulation, local treatment with dressings was provided to animals. The animals were divided into three groups: the main, or experimental, group received a medicinal product created on the basis of sodium selenite, metronidazole, and dimethyl sulfoxide; the comparison group received a dimethyl sulfoxide-based ointment; and the control group received no wound treatment.

Results. It was found that in animals of the experimental group, the combination of dimethyl sulfoxide, metronidazole, and sodium selenite resulted in the decreased duration of wound healing phases, reducing the risk of reinfection. Selenium, in turn, due to its antioxidant properties, exerted a pronounced antioxidant effect at the site of the pathological lesion, significantly improving wound reparative processes, thereby reducing the second phase of the wound healing process. Wound healing in animals of the main group occurred in 8 days, compared to 11 days in the comparison group and 16 days in the control group.

Conclusions. Taking into account the data obtained, the authors concluded about the promising use of a medicinal composition with sodium selenite, metronidazole and dimethyl sulfoxide for the local treatment of wounds.

Full Text

Restricted Access

About the authors

Evgeny V. Skvortsov

Clinical Hospital "RZD - Medicinе"

Author for correspondence.
Email: zh_scvortsov@mail.ru

Head of the Surgical Department

Russian Federation, Chita

Evgeny V. Namokonov

Chita State Medical Academy

Email: namokonovev@mail.ru

 M.D., Professor, Head of the Department of General and Specialized Surgery

Russian Federation, Chita

Nadezhda A. Shemyakina

Chita State Medical Academy

Email: shemyakina86@list.ru

Ph.D., Associate Professor of the Department of General and Specialized Surgery

Russian Federation, Chita

Tsyndyma B. Bayaskhalanova

Chita State Medical Academy

Email: bayasxalanovac@rambler.ru

Assistant of the Department of Histology, Embryology and Cytology

Russian Federation, Chita

Alexander M. Miromanov

Chita State Medical Academy

Email: miromanov_a@mail.ru

M.D., Professor, First Vice-Rector, Vice-Rector for Medical Work, Head of the Department of Traumatology and Orthopedics

Russian Federation, Chita

References

  1. Nikol'skiy VI, Zakharov AD, Shabrov AV, Venediktov AA, Glumskova YuA. Studying the oxidative stress dynamics in conditions of wound healing during implantation of an extracellular collagen matrix University proceedings. Volga region. Medical sciences. 2023; 4: 65-75. (in Russ.)
  2. Dedov II, Shestakova MV, Mayorov AY, Shamkhalova MS, Sukhareva OYu, Galstyan GR, Tokmakova AY. Diabetes mellitus type 2 in adults. Diabetes mellitus. 2020; 23(2S): 4-102. (In Russ.) https://doi.org/10.14341/DM12507
  3. Niyazov B, Mamakeev Zh, Sabitov A, Mamanov N. Modern View of the Etiology and Pathogenesis of the Wound Process (Literature Review). Bulletin of Science and Practice. 2020; 6(12): 176-190. (in Russ.). https://doi.org/10.33619/2414-2948/61/17
  4. Vorobyova AP, Bykov YV, Baturin VA, Massorov VV. The role of glycocalyx in the pathogenesis of diabetes mellitus complications. Zabajkal`skij mediczinskij vestnik. 2024; 2: 80-89. (in Russ.) https://doi.org/10.52485/19986173_2024_2_80
  5. Ushakov AA, Mitish VA, Paskhalova YuS, Magomedova SD, Borisov IV, Orudzheva Orudzheva SA. Modern dressings with enzymes for comprehensive management of various etiology wounds. Rany i ranevye infekczii. Zhurnal im. prof. B. M. Kostyuchenka. 2024; 11(2): 45-53. (in Russ.) https://doi.org/10.25199/2408-9613-2024-11-2-45-53
  6. Mitish VA, Paskhalova YuS, Eroshkin IA, Galstyan GR. Pyo-necrotic changes of the foot, critical limb ischemia and diabetes mellitus. Surgical treatment. Emergency Medical Care. 2012; 1: 35-39.
  7. Blueman D, Bluefield C. The use of larval therapy to reduce the bacterial load in chronic wounds. J. Wound Care. 2012; 21(5): 244-253.
  8. Gottrup F. Trends in surgical wound healing. Scandinavian Journal of Surgery. 2008; 97: 220-225.
  9. Malyshko VV, Basov AA, Dorohova AA, Moiseev AV, Dyakov OV, Pavlyuchenko II, Storozhuk AP. Dynamics of indicators of the prooxidant-antioxidant system in the blood and exudate under the treatment of purulent wounds with negative pressure and silver nanoparticles. Meditsinskii vestnik Severnogo Kavkaza. 2023; 18(2): 172-177. (in Russ.) https://doi.org/10.14300/mnnc.2023.18038
  10. Murashkin NN, Epishev RV, Materikin AI, Ambarchian ET, Opryatin LA, Ivanov RA. Research Institute of Pediatrics and Children’s Health in “Central Clinical Hospital of the Russian Academy of Sciences”. Voprosy sovremennoi pediatrii. 2020; 19(6): 420-431. (in Russ.) https://doi.org/10.15690/vsp.v19i6.2143
  11. Schultz GS, Sibbald RG, Falanga V, al Wound bed prepa ration: A systematic approach to wound management. Wound Repair and Regeneration.. 2003; 11 (Suppl 1): S1-S28. https://doi.org/10.1046/j.1524-475x.11.s2.1.x
  12. Belozertseva YP, Kurlayev PP, Gritsenko VA. Diabetic foot syndrome: etiology, pathogenesis, classifications and treatment. Kurskii nauchno-prakticheskii vestnik «Chelovek i ego zdorov'e». 2016; (1): 69-78. (in Russ.)
  13. Bezhin AI, Lipatov VA, Blatun LA, Fronchek EV. Morphological evaluation of the effectiveness of the use of chitosan-collagen complex with silver nano-particles and chymotrypsin in the purulent-necrotic process in soft tissues. Rany i ranevye infekczii. Zhurnal im. prof. B. M. Kostyuchenka. 2019; 4: 14-21. (in Russ.) https://doi.org/10.25199/2408-9613-2019-6-4-14-21
  14. Lutsenko VN, Namokonov EV, Grebenyuk AN, Kurapov AD. Experience in using a medicinal composition based on selenium for local treatment of wounds. Voenno-medicinskij zhurnal. 2021; 6: 69-70.
  15. Dowsett C, Davis L, Henderson V, Searle R. The economic benefits of negative pressure wound therapy in community-based wound care in the NHS. International Wound Journal. 2012; 9(5): 544-552.
  16. Safoev BB, Boltaev TSh. The use of chemical preparation of dimethyl sulfoxide in combination with the physical method in treatment of purious soft tissues. New Day in Medicine. 2020; 1(29): 398-401.
  17. Dedov DV. Selenium and selenium-containing preparations: importance for the body and prevention of various diseases. Pharmacia. 2021; 8: 54-56. (in Russ.) https://doi.org/10.29296/25419218-2021-08-09
  18. Carroll L, Davies MJ, Pattison DI. Reaction of low-molecular-mass organoselenium compounds (and their sulphur analogues) with inflammation-associated oxidants. Free Radical Res. 2015; 49(6): 750-767.
  19. Yagubov SA, Donenko FV, Kisilevsky MV. Immunomodulatory activity of metronidazole. Russian Biotherapeutic Journal. 2017; 16(s1): 86.
  20. Yalkaev AG, Kataev VA, Kildiyarov FZ. Metronidazole dosage forms with modifiable release. Bashkortostan medical journal. 2014; 6: 112-116.
  21. Sen'chukova GV. Obosnovanie sostava i standartizatsiya lekarstvennykh form, soderzhashchikh dimeksid. Avtoref. dis. kand. med. nauk. Pyatigorsk. 2001; 22. (in Russ.)
  22. Sapayeva NG, Smagulova YeN. The use of dimethyl sulfoxide with metronidazole in traumatic injuries of the oral mucosa. Science and world. 2018; 1-2(53): 73-76. (in Russ.)

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Magnification: 200x. Staining: hematoxylin-eosin. Control group on the third day: dense neutrophilic infiltration.

Download (149KB)
3. Fig. 2. Magnification: 200x. Staining: hematoxylin-eosin. Control group on the sixth day: moderate neutrophilic infiltration, occasional macrophages, lymphocytes.

Download (159KB)
4. Fig. 3. Magnification: 200x. Staining: hematoxylin-eosin. Comparison group on the third day: moderately expressed neutrophilic infiltration.

Download (177KB)
5. Fig. 4. Magnification: 200x. Staining: hematoxylin-eosin. Comparison group on the 6th day: a thin leukocytic-necrotic layer and reduced infiltration. The granulation tissue contained lymphocytes, neutrophils, immature fibroblasts, newly formed blood vessels, and lymphostasis.

Download (169KB)
6. Fig. 5. Magnification: 200x. Staining: hematoxylin-eosin. Main (experimental) group on the third day: moderately expressed neutrophilic infiltration, appearance of fibroblasts.

Download (171KB)
7. Fig. 6. Magnification: 200x. Staining: hematoxylin-eosin. Main experimental group on the sixth day: most cells are fibroblastic cells and neutrophils.

Download (173KB)

Copyright (c) 2026 Voronezh N.N. Burdenko State Medical University